Time is of the essence.... and OSL is lagging behind
Pancreatic cancer is notorious for low survival rates, but Dr Dean said new treatments in recent years had been a huge turning point.
“Patients with metastatic cancer used to be quoted a life expectancy of three or four months and now we are measuring survival in years,” he said.
https://au.news.yahoo.com/thewest/l...ctor-helps-woman-beat-pancreatic-cancer-odds/
Time is of the essence.... and OSL is lagging behind Pancreatic...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.050(4.07%) |
Mkt cap ! $16.78M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $45.65K | 37.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4883 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 558 | 1 |
View Market Depth
| Last trade - 14.48pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |